Position in ANIK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$767,455
+$89,893 QoQ
Shares Held
52,928
-24.9% QoQ
Ownership
0.398%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $516,666,064 across 52 Drug Manufacturers - Specialty & Generic names. ANIK ranks #26 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,809,925 | $213,951,231 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,745,751 | $53,210,488 | |
| 3 | VTRS |
Viatris Inc
|
3,144,439 | $42,481,369 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,400,671 | $42,188,210 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
63,005 | $37,360,703 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
243,984 | $32,142,450 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
971,854 | $13,508,770 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
639,372 | $13,273,362 |
All Filings in ANIK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $767,455 | 52,928 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $677,562 | 70,506 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $301,495 | 32,074 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $374,425 | 35,390 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $421,005 | 28,011 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $572,100 | 34,757 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $806,800 | 32,664 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $496,721 | 19,610 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $707,491 | 27,854 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $857,137 | 37,826 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $498,631 | 26,765 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $637,964 | 24,556 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $590,712 | 20,568 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $739,200 | 24,973 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $602,448 | 25,313 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $101,376 | 4,542 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $292,456 | 11,647 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $675,252 | 18,846 | Shares | Sole | 2022-02-23 | |
| 2021-09-30 | $538,511 | 12,653 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $389,003 | 8,986 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,123,234 | 27,537 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,074,019 | 23,730 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,039,581 | 29,375 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $923,554 | 24,478 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $408,757 | 14,139 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||